Licensed vaccine
TENIVAC
FDA-licensed vaccine · Sanofi Pasteur Limited · STN 103171
Key facts
| Trade name | TENIVAC |
|---|---|
| Proper name | Tetanus & Diphtheria Toxoids Adsorbed for Adult Use |
| Manufacturer | Sanofi Pasteur Limited |
| Submission tracking number (STN) | 103171 |
| FDA product areas | Biologics |
| Recent FDA documents | December 16, 2022 Approval Letter - TENIVAC, December 6, 2019 Approval Letter - TENIVAC, Package Insert-TENIVAC, Supporting Documents older than three years - TENIVAC |
| FDA page updated | Dec 19, 2022 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: